Prestige Consumer Healthcare (PBH) Q2 FY2027 earnings: revenue $336 million, up 22.7% on the year

Prestige Consumer Healthcare Inc. (PBH) reported revenue of $336 million for Q2 FY2027, the quarter ended 30 September 2026, up 22.7% on the same quarter a year earlier. Net income was $25 million, down 40.1% on the year, and diluted earnings per share $0.53. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.

Revenue

$336 million

+22.7% on the year · +26.6% on the quarter

Q3 FY2025Q2 FY2027

Operating margin

24.0%

29.1% a year earlier

Q3 FY2025Q2 FY2027

Net income

$25 million

-40.1% on the year · -13.3% on the quarter

Q3 FY2025Q2 FY2027

Diluted EPS

$0.53

-38.4% on the year · -13.1% on the quarter

Q3 FY2025Q2 FY2027

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 3 raised, 7 lowered, 1 new.

Revenue rose on acquisitions: Second-quarter revenue was $336.3 million, up 22.7%, including $65.1 million from the Breathe Right and LaCorium acquisitions. Excluding acquisitions and currency, revenue fell 1.6%.
Adjusted EPS rose, GAAP EPS fell: Adjusted diluted EPS was $1.13 against $1.07; GAAP diluted EPS was $0.53 against $0.86. Adjustments included acquisition, Pillar5 and debt-extinguishment costs.
Clear Eyes sales declined; supply limited: Clear Eyes sales declined in the quarter and first half. Production variability at Pillar5 is expected to reduce product availability and revenue in the second half.

Read the earnings call summary

Income statement (profit and loss)

$ million	Q2 FY2027	Q1 FY2027	Q2 FY2026	On the quarter	On the year
Revenue	336	266	274	+26.6%	+22.7%
Cost of revenue	164	130	123	+26.4%	+33.7%
Gross profit	173	136	152	+26.7%	+13.8%
Gross margin	51.3%	51.3%	55.3%
Operating income	80.7	52.5	79.7	+53.7%	+1.3%
Operating margin	24.0%	19.8%	29.1%
Interest expense	n/a	13.9	n/a
Income tax	22.2	9.4	26.9	+136.6%	-17.7%
Net income	25.3	29.2	42.2	-13.3%	-40.1%
Net margin	7.5%	11.0%	15.4%
Diluted EPS	$0.53	$0.61	$0.86	-13.1%	-38.4%

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	Q2 FY2027	Q1 FY2027	Q2 FY2026	On the quarter	On the year
Operating cash flow	37.9	70.8	57.5	-46.5%	-34.1%
Capital expenditure	3.6	3.7	2.1	-2.1%	+72.4%
Free cash flow	34.2	67.1	55.4	-49.0%	-38.2%
Free cash flow margin	10.2%	25.2%	20.2%
Cash from investing	-139	-1,064	-2.9
Cash from financing	58.3	1,018	-74.9	-94.3%
Depreciation and amortisation	12.0	8.8	7.7	+36.7%	+56.1%
Share-based compensation	1.2	4.0	1.8	-69.2%	-30.3%
Buybacks	0.0	0.0	75.0
Diluted shares, weighted	48m	48m	49m	-0.0%	-3.4%
Shares outstanding at period end	47m	47m	48m	+0.0%	-1.4%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ million	Q2 FY2027	Q1 FY2027	Q2 FY2026	On the quarter	On the year
Shareholders' equity	1,945	1,917	1,825	+1.5%	+6.6%
Debt	2,079	2,018	993	+3.1%	+109.4%
Operating lease liabilities	17.5	19.1	19.9	-8.5%	-12.2%
Finance lease liabilities	16.6	17.3	19.3	-4.1%	-14.2%
Other liabilities	664	598	585	+11.0%	+13.5%
Total liabilities and equity	4,722	4,569	3,442	+3.4%	+37.2%
Fixed assets	117	117	73.1	-0.3%	+59.9%
Goodwill	705	651	528	+8.4%	+33.5%
Intangible assets	3,357	3,243	2,291	+3.5%	+46.5%
Cash and equivalents	46.5	89.1	119	-47.8%	-60.9%
Receivables	244	187	199	+30.3%	+22.7%
Inventory	179	190	159	-5.8%	+12.7%
Other assets	72.6	90.5	72.6	-19.8%	+0.0%
Total assets	4,722	4,569	3,442	+3.4%	+37.2%

Questions

What was Prestige Consumer Healthcare's revenue in Q2 FY2027?

Prestige Consumer Healthcare (PBH) reported revenue of $336 million for Q2 FY2027, the quarter ended 30 September 2026, up 22.7% on the same quarter a year earlier.

How much did Prestige Consumer Healthcare earn in Q2 FY2027?

Net income for Q2 FY2027 was $25 million, down 40.1% on the year, and diluted earnings per share $0.53.

When did Prestige Consumer Healthcare report Q2 FY2027 results?

Prestige Consumer Healthcare filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.

Quarterly results, the last 20 quarters

	Q3 FY2022	Q4 FY2022 *	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026	Q4 FY2026 *	Q1 FY2027	Q2 FY2027
Revenue	274	267	277	289	276	286	279	286	283	277	267	284	290	297	250	274	283	282	266	336
Cost of revenue	119	118	117	128	125	132	125	126	125	125	121	126	129	127	109	123	126	135	130	164
Gross profit	155	149	160	161	150	154	155	160	158	152	146	157	161	170	140	152	157	146	136	173
Gross margin	56%	56%	58%	56%	55%	54%	55%	56%	56%	55%	55%	55%	55%	57%	56%	55%	56%	52%	51%	51%
Operating income	82.6	77.4	87.0	84.4	87.2	-281	85.2	88.2	86.8	82.2	72.0	84.3	92.0	88.4	71.8	79.7	82.5	75.5	52.5	80.7
Operating margin	30%	29%	31%	29%	32%	-98%	31%	31%	31%	30%	27%	30%	32%	30%	29%	29%	29%	27%	20%	24%
Interest expense	n/a	n/a	n/a	n/a	n/a	n/a	17.7	17.6	16.6	n/a	13.1	12.3	11.5	-35.1	10.2	n/a	n/a	n/a	13.9	n/a
Net income	50.2	52.1	55.3	51.0	52.0	-241	53.3	53.6	53.0	49.5	49.1	54.4	61.0	50.1	47.5	42.2	46.7	53.9	29.2	25.3
Net margin	18%	20%	20%	18%	19%	-84%	19%	19%	19%	18%	18%	19%	21%	17%	19%	15%	16%	19%	11%	8%
Diluted EPS	$0.99	$1.02	$1.09	$1.02	$1.04	-$4.83	$1.06	$1.07	$1.06	$0.98	$0.98	$1.09	$1.22	$1.00	$0.95	$0.86	$0.97	$1.13	$0.61	$0.53
Operating cash flow	66.3	63.1	58.2	57.5	54.9	59.0	48.1	62.5	71.5	66.9	54.8	69.8	65.1	61.8	79.0	57.5	78.3	42.8	70.8	37.9
Capital expenditure	2.2	3.2	1.0	2.4	1.8	2.6	1.5	2.9	2.0	3.1	1.2	2.0	1.6	3.5	0.8	2.1	3.0	5.2	3.7	3.6
Free cash flow	64.1	60.0	57.2	55.2	53.1	56.4	46.6	59.5	69.5	63.8	53.6	67.8	63.5	58.4	78.2	55.4	75.3	37.6	67.1	34.2
Buybacks	0.0	0.0	37.7	12.3	0.0	0.0	25.0	0.0	0.0	0.0	26.0	11.8	2.4	11.3	34.8	75.0	45.8	0.7	0.0	0.0
Shares outstanding	50m	50m	50m	50m	50m	50m	50m	50m	50m	50m	50m	49m	50m	49m	49m	48m	47m	47m	47m	47m
Filing	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.